These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 23021659

  • 1. [Treatment of chronic hepatitis viral C: new associations].
    Ouzan D.
    Presse Med; 2013 Jun; 42(6 Pt 1):977-82. PubMed ID: 23021659
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors.
    Coppola N, Pisaturo M, Sagnelli C, Sagnelli E, Angelillo IF.
    PLoS One; 2014 Jun; 9(4):e94542. PubMed ID: 24728219
    [Abstract] [Full Text] [Related]

  • 9. Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis.
    Cooper C, Lester R, Thorlund K, Druyts E, El Khoury AC, Yaya S, Mills EJ.
    QJM; 2013 Feb; 106(2):153-63. PubMed ID: 23159839
    [Abstract] [Full Text] [Related]

  • 10. Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.
    Zimmermann T, Hueppe D, Mauss S, Buggisch P, Pfeiffer-Vornkahl H, Grimm D, Galle PR, Alshuth U.
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):15-24. PubMed ID: 27014750
    [Abstract] [Full Text] [Related]

  • 11. A new era in the treatment of chronic hepatitis C infection.
    Jothimani D, Chandy GM, Conjeevaram H.
    Indian J Gastroenterol; 2013 Mar; 32(2):71-9. PubMed ID: 23054947
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France.
    Aherfi S, Solas C, Motte A, Moreau J, Borentain P, Mokhtari S, Botta-Fridlund D, Dhiver C, Portal I, Ruiz JM, Ravaux I, Bregigeon S, Poizot-Martin I, Stein A, Gérolami R, Brouqui P, Tamalet C, Colson P.
    J Med Virol; 2014 Nov; 86(11):1868-76. PubMed ID: 25052594
    [Abstract] [Full Text] [Related]

  • 14. Boceprevir for chronic HCV genotype 1 infection.
    Limaye AR, Draganov PV, Cabrera R.
    N Engl J Med; 2011 Jul 14; 365(2):176; author reply 177-8. PubMed ID: 21751914
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Triple therapy with boceprevir or telaprevir for prior HCV non-responders.
    Asselah T.
    Best Pract Res Clin Gastroenterol; 2012 Aug 14; 26(4):455-62. PubMed ID: 23199504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.